Combined approach of carotid endarteriectomy and transcarotid transcatheter aortic valve implantation as a minimally invasive one-step treatment of aortic stenosis: a case report.
Aortic stenosis
Case report
Minimally invasive
TAVI
TAVR
Transcarotid-TAVI
Journal
European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
05
07
2022
revised:
05
09
2022
accepted:
12
04
2023
medline:
14
5
2023
pubmed:
14
5
2023
entrez:
14
5
2023
Statut:
epublish
Résumé
Despite the gold-standard approach for transaortic valve implantation (TAVI) remains transfemoral (TF), alternative approaches are needed in patients who present contraindications to transfemoral access. We report the case of a 79-year-old female with a symptomatic high-gradient severe aortic stenosis-mean gradient of 43 mmHg-and a significant supra-aortic trunk stenosis (left carotid artery: 90-99%; right carotid artery: 50-70%), and who was hospitalized for progressive dyspnoea New York Heart Association (NYHA) stage III. In this high-risk patient, it was decided to perform a TAVI. Because of a history of stenting of both common iliac arteries in a context of an arterial insufficiency of the lower limbs (Leriche classification stage III) and stenotic thoraco-abdominal aorta atheromatosis, an alternative approach to the transfemoral transaortic valve implantation (TF-TAVI) one was needed. It was decided to perform a combined transcarotid-TAVI (TC-TAVI) with EDWARDS S3 23 mm valve with a left endarteriectomy during the same operating time. Our case illustrates an alternative approach to perform a percutaneous aortic valve implantation, despite supra-aortic trunk stenosis, in a high-risk surgical patient contraindicated to a TF-TAVI. Transcarotid transaortic valve implantation remains a safe alternative when TF-TAVI is contraindicated, and the combined approach of carotid endarteriectomy and TC-TAVI offers a minimally invasive one-step treatment in high operative risk patients.
Sections du résumé
Background
UNASSIGNED
Despite the gold-standard approach for transaortic valve implantation (TAVI) remains transfemoral (TF), alternative approaches are needed in patients who present contraindications to transfemoral access.
Case summary
UNASSIGNED
We report the case of a 79-year-old female with a symptomatic high-gradient severe aortic stenosis-mean gradient of 43 mmHg-and a significant supra-aortic trunk stenosis (left carotid artery: 90-99%; right carotid artery: 50-70%), and who was hospitalized for progressive dyspnoea New York Heart Association (NYHA) stage III. In this high-risk patient, it was decided to perform a TAVI. Because of a history of stenting of both common iliac arteries in a context of an arterial insufficiency of the lower limbs (Leriche classification stage III) and stenotic thoraco-abdominal aorta atheromatosis, an alternative approach to the transfemoral transaortic valve implantation (TF-TAVI) one was needed. It was decided to perform a combined transcarotid-TAVI (TC-TAVI) with EDWARDS S3 23 mm valve with a left endarteriectomy during the same operating time.
Discussion
UNASSIGNED
Our case illustrates an alternative approach to perform a percutaneous aortic valve implantation, despite supra-aortic trunk stenosis, in a high-risk surgical patient contraindicated to a TF-TAVI. Transcarotid transaortic valve implantation remains a safe alternative when TF-TAVI is contraindicated, and the combined approach of carotid endarteriectomy and TC-TAVI offers a minimally invasive one-step treatment in high operative risk patients.
Identifiants
pubmed: 37181472
doi: 10.1093/ehjcr/ytad184
pii: ytad184
pmc: PMC10171836
doi:
Types de publication
Case Reports
Langues
eng
Pagination
ytad184Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: None declared.
Références
Int J Cardiol. 2021 Mar 15;327:58-62
pubmed: 33242507
Circ J. 2018 Sep 25;82(10):2518-2522
pubmed: 30068794
J Cardiol. 2018 Jun;71(6):525-533
pubmed: 29499894
Indian J Thorac Cardiovasc Surg. 2019 Jan;35(1):55-58
pubmed: 33060970
Eur Heart J Case Rep. 2020 Nov 24;4(6):1-6
pubmed: 33447700